Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-02

Clinical Trial Update: Testing the Effects of Methylphenidate on Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of methylphenidate on fatigue in individuals with multiple sclerosis has completed. The document is a status upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Kessler Foundation | Conditions: Fatigue in Multiple Sclerosis | Phase 2 | Status: COMPLETED